Provided by Tiger Trade Technology Pte. Ltd.

Gyre Therapeutics

6.94
-0.1000-1.42%
Pre-market: 7.070.1300+1.87%08:00 EDT
Volume:117.36K
Turnover:821.08K
Market Cap:672.93M
PE:308.66
High:7.24
Open:7.00
Low:6.91
Close:7.04
52wk High:11.78
52wk Low:6.11
Shares:96.96M
Float Shares:20.52M
Volume Ratio:0.68
T/O Rate:0.57%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.0225
EPS(LYR):0.0481
ROE:8.21%
ROA:4.93%
PB:6.35
PE(LYR):144.35

Loading ...

Mar 15, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 14, 2024

Major Issues Report

Form 8-K - Current report
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jan 24, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Jan 20, 2024

Major Issues Report

Form 8-K/A - Current report: [Amend]
Jan 13, 2024

Major Issues Report

Form 8-K/A - Current report: [Amend]
Dec 15, 2023

Major Issues Report

Form 8-K - Current report
Dec 07, 2023

Major Issues Report

Form 8-K - Current report
Nov 27, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Nov 14, 2023

Major Issues Report

Form 8-K - Current report
Nov 13, 2023

Major Issues Report

Form 8-K - Current report
Nov 06, 2023

Major Issues Report

Form 8-K - Current report
Nov 02, 2023

Major Issues Report

Form 8-K - Current report
Nov 01, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Oct 31, 2023

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Oct 31, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Oct 30, 2023

Major Issues Report

Form 8-K - Current report
Oct 27, 2023

Major Issues Report

Form 8-K - Current report
Oct 25, 2023

Correspondence

Form CORRESP - Correspondence
Oct 14, 2023

Correspondence

Form CORRESP - Correspondence